Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center. 2021

Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
Virginia Commonwealth University School of Medicine, Richmond, Virginia.

UI MeSH Term Description Entries
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000046 Academic Medical Centers Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. Medical Centers, Academic,Medical Centers, University,University Medical Centers,Academic Medical Center,Center, Academic Medical,Center, University Medical,Centers, Academic Medical,Centers, University Medical,Medical Center, Academic,Medical Center, University,University Medical Center
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
May 2021, Studies in health technology and informatics,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
January 2021, Journal of emergency management (Weston, Mass.),
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
August 2021, Hospital pharmacy,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
September 2020, Cancer medicine,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
January 2022, American journal of medical quality : the official journal of the American College of Medical Quality,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
April 2022, Disaster medicine and public health preparedness,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
September 2022, Infection control and hospital epidemiology,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
October 2021, Infection control and hospital epidemiology,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
November 2021, The journal of applied laboratory medicine,
Matthew J Nestler, and Emily Godbout, and Kimberly Lee, and Jihye Kim, and Andrew J Noda, and Perry Taylor, and Rachel Pryor, and J Daniel Markley, and Michelle Doll, and Gonzalo Bearman, and Michael P Stevens
January 2021, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!